INS and type 2 diabetes mellitus: Insulin β-cell function index (HOMA-β) were elevated [18] because glimepiride decomposes a large number of free fatty acids in the patient's body, inhibits excessive carbon monoxide synthase, reduces cell damage, and gradually restores islet β-cell function normal, so that liver-derived glucose is broken down rapidly, reducing blood sugar in type 2 diabetes patients.